Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -10.43%207.81M | 1.46%250.63M | -37.48%198.12M | -15.31%285.02M | -48.08%232.02M | -53.47%247.03M | -14.36%316.87M | -16.44%336.53M | 4.02%446.85M | 33.06%530.91M |
Transactional financial assets | -40.00%60M | --60M | --100M | --100M | --100M | --0 | ---- | ---- | --0 | ---- |
Notes receivable and accounts receivable | 10.24%253.9M | -27.13%237.61M | -11.07%234.32M | -14.80%236.41M | -19.72%230.32M | 28.33%326.09M | 17.11%263.48M | 33.42%277.46M | 19.22%286.9M | 40.81%254.09M |
-Accounts receivable | 10.24%253.9M | -27.13%237.61M | -11.07%234.32M | -14.80%236.41M | -19.72%230.32M | 28.33%326.09M | 17.11%263.48M | 33.42%277.46M | 19.22%286.9M | 40.81%254.09M |
Other receivables (including interest and dividends) | 76.52%3.61M | 76.92%3.51M | 35.81%2.73M | 41.35%2.75M | -31.47%2.04M | 2.48%1.98M | -19.75%2.01M | -15.87%1.95M | 29.28%2.98M | 46.88%1.94M |
-Dividend receivable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Accrued interest receivable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Other receivable | 76.52%3.61M | 76.92%3.51M | 35.81%2.73M | 41.35%2.75M | -31.47%2.04M | 2.48%1.98M | -19.75%2.01M | -15.87%1.95M | 29.28%2.98M | 46.88%1.94M |
Advance payment | -81.14%10.69M | -42.71%7.01M | -33.36%27.77M | -11.05%28.48M | 92.71%56.7M | -11.63%12.24M | -33.04%41.67M | 62.34%32.02M | -31.78%29.42M | 30.52%13.86M |
Inventories | -2.03%343.56M | -6.02%354.03M | -11.93%339.28M | 2.67%384.65M | -3.00%350.68M | 12.87%376.71M | 16.82%385.23M | 45.90%374.67M | 46.78%361.53M | 51.33%333.76M |
Receivable financing | 21.38%60.12M | -38.06%24.55M | 45.29%50.38M | 115.98%31.75M | 89.08%49.53M | 117.96%39.63M | -19.35%34.67M | -69.58%14.7M | -38.52%26.19M | -70.07%18.18M |
Other current assets | 32.12%42.72M | 20.47%40.58M | 40.76%31.04M | -17.76%38.39M | 10.77%32.33M | 34.91%33.68M | 546.88%22.05M | --46.67M | --29.19M | 475.35%24.97M |
Total current assets | -6.76%982.41M | -5.73%977.92M | -7.72%983.64M | 2.16%1.11B | -10.94%1.05B | -11.92%1.04B | -10.86%1.07B | -4.73%1.08B | -3.39%1.18B | 5.43%1.18B |
Non Current assets | ||||||||||
Other equity investment | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M | 0.00%17M |
Other non-current financial assets | 0.00%60M | 0.00%60M | 0.00%60M | 0.00%60M | --60M | --60M | --60M | --60M | ---- | --0 |
Long-term equity investment | -23.36%10.85M | -23.36%10.85M | -17.58%13.17M | -17.58%13.17M | -81.50%14.16M | -11.40%14.16M | -6.63%15.98M | -6.63%15.98M | 349.47%76.51M | -6.63%15.98M |
Fixed assets | ---- | ---- | ---- | 13.59%1.38B | ---- | 71.03%1.39B | ---- | 95.69%1.22B | ---- | 23.25%810.63M |
Constru in process | ---- | ---- | ---- | 41.52%296.25M | ---- | -38.38%264.94M | ---- | 12.46%209.33M | ---- | 316.58%429.97M |
Construction materials | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | --0 |
Intangible assets | -4.37%153.58M | -4.45%154.56M | -4.22%158.23M | -3.97%159.72M | -4.53%160.59M | -2.33%161.77M | 8.02%165.2M | 66.52%166.32M | 70.28%168.21M | 66.71%165.63M |
Goodwill | -42.02%131.36M | -42.02%131.36M | -37.24%226.57M | -37.24%226.57M | -37.24%226.57M | -37.24%226.57M | 1.23%360.99M | 55.31%360.99M | 55.31%360.99M | 55.31%360.99M |
Long deferred expense | -18.12%2.4M | -20.64%2.52M | -26.13%2.62M | -27.79%2.77M | -30.52%2.92M | -30.77%3.17M | -27.60%3.54M | 22.34%3.84M | 30.60%4.21M | 38.44%4.58M |
Deferred tax assets | 223.46%52.51M | 197.09%51.04M | 693.26%34.76M | 523.77%27.94M | 140.18%16.23M | 92.32%17.18M | -78.07%4.38M | -61.47%4.48M | -44.23%6.76M | -33.23%8.93M |
Other non current assets | 213.00%18.84M | 692.51%20.28M | 662.14%74.08M | 2.37%75.23M | -78.38%6.02M | -83.92%2.56M | -83.70%9.72M | 109.54%73.49M | 606.54%27.84M | 296.41%15.92M |
Total non current assets | 4.46%2.25B | 2.85%2.22B | 4.27%2.29B | 6.23%2.26B | 10.44%2.16B | 17.72%2.15B | 35.08%2.2B | 73.85%2.13B | 69.93%1.95B | 59.44%1.83B |
Total assets | 0.78%3.24B | 0.06%3.19B | 0.35%3.28B | 4.86%3.37B | 2.38%3.21B | 6.11%3.19B | 15.63%3.27B | 35.99%3.21B | 32.11%3.14B | 32.80%3.01B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 3.31%655.49M | 25.95%644.66M | 25.89%626.18M | 57.45%641.53M | 35.59%634.5M | 20.34%511.85M | 19.29%497.4M | -2.16%407.45M | 33.01%467.94M | 32.13%425.35M |
Notes payable and accounts payable | 29.92%356.46M | -14.73%335.2M | -18.64%288.36M | 1.07%352.82M | -0.62%274.38M | 57.02%393.12M | 70.13%354.41M | 96.55%349.09M | 40.84%276.1M | 69.91%250.37M |
-Notes payable | 23.16%51.63M | 38.77%71.99M | -61.08%33.9M | -55.15%48.9M | -50.30%41.92M | -26.43%51.88M | 66.18%87.09M | 581.53%109.05M | --84.34M | --70.51M |
-Accounts payable | 31.13%304.84M | -22.87%263.21M | -4.81%254.47M | 26.61%303.92M | 21.23%232.46M | 89.73%341.24M | 71.46%267.31M | 48.54%240.04M | -2.18%191.76M | 22.06%179.85M |
Contract liabilities | 32.06%12.35M | -34.39%5.8M | -36.59%9.06M | -9.27%4.52M | 121.49%9.35M | 123.01%8.84M | 196.36%14.29M | 1.26%4.99M | -35.17%4.22M | -76.50%3.96M |
Salaries payable | 9.36%16.58M | 3.60%31.48M | 6.67%29.61M | 40.32%24.02M | 56.98%15.17M | 2.84%30.39M | 0.15%27.76M | -13.87%17.12M | -30.83%9.66M | 24.30%29.55M |
Taxs payable | -69.18%5.57M | -56.61%7.24M | 301.71%11.42M | 107.96%12.04M | 211.15%18.08M | -19.49%16.69M | -69.15%2.84M | -41.53%5.79M | -60.70%5.81M | 63.31%20.73M |
Other payable (including interest and dividends) | -62.90%10M | -61.30%11.27M | -63.52%10.62M | -6.32%27.27M | -33.86%26.97M | -28.59%29.12M | -28.91%29.11M | -27.19%29.1M | -7.09%40.77M | -9.20%40.78M |
-Interest payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Dividend payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Other payable | -62.90%10M | -61.30%11.27M | -63.52%10.62M | -6.32%27.27M | -33.86%26.97M | -28.59%29.12M | --29.11M | -27.19%29.1M | --40.77M | -9.20%40.78M |
Non current liabilities due within one year | --174.08M | --212.58M | ---- | --0 | ---- | --0 | --1.25M | --874.97K | -99.43%365.52K | -99.62%246.69K |
Other current liabilities | 55.17%1.61M | -24.99%753.86K | -36.62%1.18M | -9.28%587.7K | 88.50%1.03M | 95.25%1M | 202.96%1.86M | 7.26%647.82K | 159.33%548.91K | -75.92%514.73K |
Total current liabilities | 25.80%1.23B | 26.03%1.25B | 5.12%976.44M | 30.39%1.06B | 21.61%979.48M | 28.45%991.02M | 31.10%928.92M | 21.78%815.06M | 16.51%805.42M | 21.74%771.5M |
Current liabilities | ||||||||||
Long term loan | -13.21%391.52M | -20.18%338.87M | 40.30%552.59M | 30.26%541.03M | 63.83%451.13M | 98.20%424.54M | 165.48%393.86M | --415.36M | --275.36M | --214.2M |
Estimate liabilities | --5.51M | --5.51M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Deferred tax liabilities | 6.99%18.34M | -12.97%18.38M | -36.83%20.89M | -31.32%20.96M | -53.02%17.14M | -38.24%21.11M | -33.01%33.07M | -11.13%30.52M | 6.24%36.49M | -0.44%34.19M |
Long term deferred income | 39.53%46.2M | 41.26%45.6M | 39.28%46.41M | 28.86%40.27M | 2.87%33.11M | 2.14%32.28M | 39.72%33.32M | 32.56%31.25M | 161.37%32.19M | 169.08%31.6M |
Total non current liabilities | -7.94%461.56M | -14.56%408.35M | 34.68%619.88M | 26.23%602.27M | 45.74%501.39M | 70.69%477.93M | 107.72%460.25M | 723.79%477.13M | 637.37%344.04M | 507.55%279.99M |
Total liabilities | 14.37%1.69B | 12.83%1.66B | 14.91%1.6B | 28.85%1.67B | 28.83%1.48B | 39.70%1.47B | 49.35%1.39B | 77.69%1.29B | 55.76%1.15B | 54.67%1.05B |
Shareholders equity | ||||||||||
Paid-in capital | -0.76%325.47M | -0.76%325.47M | -0.76%325.47M | 0.00%327.96M | 0.00%327.96M | 0.00%327.96M | 0.00%327.96M | 0.00%327.96M | 40.00%327.96M | 40.30%327.96M |
Capital reserve funds | -1.46%911.13M | -1.46%911.13M | -2.64%912.25M | -1.47%924.63M | -1.01%924.63M | -0.95%924.63M | 0.68%936.99M | 1.22%938.43M | -8.13%934.03M | -7.38%933.49M |
Surplus reserve funds | 0.00%61.5M | 0.00%61.5M | 1.47%61.5M | -2.99%61.5M | -3.91%61.5M | 0.00%61.5M | 6.72%60.61M | 17.12%63.39M | 27.32%64M | 29.62%61.5M |
Retained profit | -97.99%3.79M | -99.64%677.83K | -57.56%143.21M | -57.03%163.08M | -59.40%188.76M | -57.68%186.2M | -11.71%337.47M | 6.97%379.55M | 26.68%464.87M | 34.27%439.97M |
Less:Treasury stock | ---- | ---- | --0 | 0.00%16.19M | -44.51%16.19M | -44.51%16.19M | -44.51%16.19M | -44.51%16.19M | -8.95%29.18M | -8.95%29.18M |
Specific reserves | ---- | ---- | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
Shareholders equity without minority interests | -12.43%1.3B | -12.49%1.3B | -12.41%1.44B | -13.71%1.46B | -15.61%1.49B | -14.40%1.48B | -1.30%1.65B | 3.57%1.69B | 7.67%1.76B | 9.40%1.73B |
Minority interests | -1.23%240.51M | -0.47%236.99M | 3.81%238.46M | 6.75%242.28M | 8.07%243.49M | 7.21%238.11M | 1.77%229.7M | --226.95M | --225.31M | --222.1M |
Total shareholder equity | -10.85%1.54B | -10.83%1.54B | -10.43%1.68B | -11.29%1.7B | -12.93%1.73B | -11.95%1.72B | -0.93%1.88B | 17.45%1.92B | 21.45%1.99B | 23.42%1.96B |
Total liabilityies and equity | 0.78%3.24B | 0.06%3.19B | 0.35%3.28B | 4.86%3.37B | 2.38%3.21B | 6.11%3.19B | 15.63%3.27B | 35.99%3.21B | 32.11%3.14B | 32.80%3.01B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.